Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6016041 | Epilepsy Research | 2012 | 10 Pages |
Abstract
Despite higher acquisition costs for branded pregabalin over generic gabapentin, overall direct and indirect costs trended lower for pregabalin users. Additionally, pregabalin users had significantly fewer sick leave days and significantly higher adherence rates than gabapentin users.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Nathan L. Kleinman, Alesia Sadosky, Jaren Seid, Roy C. Martin, David M. Labiner,